Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5
Kondapa Naidu Bobba(University of California, San Francisco), Robert R. Flavell(University of California, San Francisco)
Cited by 27
Related Papers
Efficient Semisynthesis of a Tetraphosphorylated Analogue of the Type I TGFβ Receptor
|Organic Letters|2001|55
FRET-based dual channel fluorescent probe for detecting endogenous/exogenous H2O2/H2S formation through multicolor images
|Journal of Photochemistry and Photobiology B Biology|2018|40
<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with<sup>18</sup>F-FDG
|Journal of Nuclear Medicine|2024|36
Treatment of prostate cancer with CD46 targeted <sup>225</sup> Ac alpha particle radioimmunotherapy
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0